International Journal of Drug Policy
Volume 21, Issue 6 , Pages 511-513 , November 2010

Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer

  • Nicholas T. Van Dam
    • ,
  • Mitch Earleywine

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Psychology, University at Albany, Social Sciences 399, 1400 Washington Ave, Albany, NY 12222, United States. Tel.: +1 518 442 4836; fax: +1 518 442 4867.

Received 24 February 2010 ,Revised 25 March 2010 ,Accepted 4 April 2010.

References 

  1. Abrams DI, Vizoso HP, Shade SB, Jay C, Kelly ME, Benowitz NL. Vaporization as a smokeless cannabis delivery system: A pilot study. Clinical Pharmacology & Therapeutics. 2007;82:572–578
  2. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of lung health study participants after 11 years. American Journal of Respiratory and Critical Care Medicine. 2002;166:675–679
  3. Armeli S, Carney M, Tennen H, Affleck G, O’Neil T. Stress and alcohol use: A daily process examination of the stressor-vulnerability model. Journal of Personality and Social Psychology. 2000;78:979–994
  4. Blake GH, Abell TD, Stanley WG. Cigarette smoking and upper respiratory infection among recruits in basic combat training. Annals of Internal Medicine. 1988;109:198–202
  5. Degenhardt L, Hall WD. The adverse effects of cannabinoids: Implications for use of medical marijuana. Canadian Medical Association Journal. 2008;178:1685–1686
  6. Earleywine M, Smucker Barnwell S. Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduction Journal. 2007;4:11
  7. Earleywine, M. & Van Dam, N.T. (in press). Case studies in cannabis vaporization. Addiction Research and Theory.
  8. Gieringer D, St. Laruent J, Goodrich S. Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compounds. Journal of Cannabis Therapeutics. 2004;4:7–27
  9. Hall W. The adverse health effects of cannabis use: What are they, and what are their implications for policy?. International Journal of Drug Policy. 2009;20:458–466
  10. Hall W, Christie M, Currow D. Cannabinoids and cancer: Causation, remediation, and palliation. Lancet Oncology. 2005;6:35–42
  11. Melamede R. Cannabis and tobacco smoke are not equally carcinogenic. Harm Reduction Journal. 2005;2:21
  12. O’Connor SA, Jones DP, Collins JV, Heath RB, Campbell MJ, Leighton MH. Changes in pulmonary function after naturally acquired respiratory infection in normal persons. The American Review of Respiratory Disease. 1979;120:1087–1093
  13. Rappaport EB, Gilliland FD, Linn WS, Gauderman WJ. Impact of respiratory illness on expiratory flow rates in normal, asthmatic, and allergic children. Pediatric Pulmonology. 2002;34:112–121
  14. Robertson JR, Miller P, Anderson R. Cannabis use in the community. British Journal of General Practice. 1996;46:671–674
  15. Sobell LC, Sobell MB. Alcohol timeline followback. In: American Psychiatric Association  editors. Handbook of psychiatric measures. Washington D.C: American Psychiatric Association; 2000;p. 477–479
  16. Tashkin DR, Baldwin GC, Sarafian T, Dubinett S, Roth MD. Respiratory and immunologic consequences of marijuana smoking. Journal of Clinical Pharmacology. 2002;42:71S–81S
  17. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications. Archives of Internal Medicine. 2007;167:221–228
  18. Volkova NB, Kodani A, Hilario D, Munyaradzi SM, Peterson MW. Spirometry utilization after hospitalization for patients with chronic obstructive pulmonary disease exacerbations. American Journal of Medical Quality. 2009;24:61–66
  19. Walden N, Earleywine M. How high? Quantity as a predictor of cannabis-related problems. Harm Reduction Journal. 2008;5:20
  20. Wang T, Collet J-P, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: A systematic review. Canadian Medical Association Journal. 2008;17:1669–1678

PII: S0955-3959(10)00069-1

doi: 10.1016/j.drugpo.2010.04.001

International Journal of Drug Policy
Volume 21, Issue 6 , Pages 511-513 , November 2010

Article Tools